Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-25-022289
Filing Date
2025-11-13
Accepted
2025-11-13 16:05:52
Documents
60
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q form10-q.htm   iXBRL 10-Q 1263135
2 EX-31.1 ex31-1.htm EX-31.1 12862
3 EX-31.2 ex31-2.htm EX-31.2 12636
4 EX-32.1 ex32-1.htm EX-32.1 7139
5 EX-32.2 ex32-2.htm EX-32.2 7335
  Complete submission text file 0001493152-25-022289.txt   5952388

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE exoz-20250930.xsd EX-101.SCH 38965
7 XBRL CALCULATION FILE exoz-20250930_cal.xml EX-101.CAL 48480
8 XBRL DEFINITION FILE exoz-20250930_def.xml EX-101.DEF 162066
9 XBRL LABEL FILE exoz-20250930_lab.xml EX-101.LAB 350088
10 XBRL PRESENTATION FILE exoz-20250930_pre.xml EX-101.PRE 265661
62 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1004454
Mailing Address 750 ROYAL OAKS DR MONROVIA CA 91016
Business Address 750 ROYAL OAKS DR MONROVIA CA 91016 (626) - 415 - 1488
EXOZYMES INC. (Filer) CIK: 0002010788 (see all company filings)

EIN.: 834550057 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-42204 | Film No.: 251478366
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)